Table 1.
Clinical patient characteristics
| Characteristic | n = 86 |
|---|---|
| Age (years): median, range | 72, 21–92 |
| Sex | |
| Female | 40 (47%) |
| Occlusion site | |
| MCA | 50 (58%) |
| ICA including carotid-T | 22 (26%) |
| Combined ICA and MCA/ACA | 13 (15%) |
| ACA | 1 (1%) |
| Baseline NIHSS (range, median), n = 81 (94.2%) | 15, 2–27 |
| IV rtPA | 57 (66%) |
| Time symptom onset to reperfusion (min): median, range, n = 70 (81.4%) | 280 (0–495) |
| mRS (90 days), n = 41 (47.7%) | |
| 0–2 | 17 (39.1%) |
| > 2 | 24 (60.9%) |
| Stroke etiology (TOAST), n = 85 | |
| 1 = arterioembolic | 16 (18.8%) |
| 2 = cardioembolic | 40 (47.1%) |
| 4 = other determined cause | 9 (10.6%) |
| 5 = cryptogenic | 20 (23.5%) |
Basic demographic and clinical patient characteristics (MCA middle cerebral artery, ICA internal carotid artery, ACA anterior cerebral artery, IV rtPA intravenous recombinant tissue plasminogen activator)